Page last updated: 2024-11-05

diethyl succinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethyl succinate is a colorless liquid with a pleasant odor. It is synthesized by the esterification of succinic acid with ethanol. The esterification reaction typically involves the use of a strong acid catalyst, such as sulfuric acid. It is commonly used as a solvent and as an intermediate in the production of other organic compounds. It serves as a precursor in organic synthesis for the production of pharmaceuticals, pesticides, and other chemicals. Diethyl succinate is also used in the manufacture of polymers, resins, and plasticizers. Due to its diverse applications, diethyl succinate is a subject of ongoing research and development.'

diethyl succinate: carboxylesterase substrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31249
CHEMBL ID369243
CHEBI ID169507
SCHEMBL ID22780
MeSH IDM0149811

Synonyms (64)

Synonym
1,4-diethyl butanedioate
EN300-18004
CHEBI:169507
butanedioic acid diethyl ester
fema no. 2377
nsc 8875
einecs 204-612-0
brn 0907645
diethylester kyseliny jantarove [czech]
diethyl butanedioate
diethyl ethanedicarboxylate
ai3-00682
nsc-8875
ethyl succinate
123-25-1
wln: 2ov2vo2
diethyl succinate
nsc8875
inchi=1/c8h14o4/c1-3-11-7(9)5-6-8(10)12-4-2/h3-6h2,1-2h
succinic acid, diethyl ester
butanedioic acid, diethyl ester
diethyl succinate, >=99%, fcc, fg
diethyl succinate, reagentplus(r), 99%
AKOS000269055
FT-0653029
CHEMBL369243
succinic acid diethyl ester
NCGC00247986-01
NCGC00253946-01
cas-123-25-1
tox21_300286
dtxsid2038732 ,
dtxcid0018732
68989-32-2
4-02-00-01914 (beilstein handbook reference)
diethylester kyseliny jantarove
unii-elp55c13dr
butanedioic acid, 1,4-diethyl ester
elp55c13dr ,
diethyl succinate [fhfi]
diethyl succinate [inci]
succinic acid diethyl ester [mi]
diethyl succinate [fcc]
S6209
diethylsuccinate
SCHEMBL22780
diethyl ester of butanedioic acid
Q-100106
mfcd00009208
F0001-0363
diethyl succinate, 98%
diethyl succinate, analytical standard
diethyl succinate, natural, >=99%, fg
diethyl succinate, vetec(tm) reagent grade, 98%
succinic acid-diethyl ester
diethyl butanoate
Z57127474
DS-7133
Q1978959
STL194305
CS-0015811
HY-Y0836
SY011286
F70092
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
fatty acid esterA carboxylic ester in which the carboxylic acid component can be any fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency68.51990.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency1.09570.000221.22318,912.5098AID743036
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.51990.003041.611522,387.1992AID1159555
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID121647In vivo antileukemic activity against P-388 lymphocytic leukemia in BDF1 male mice at 60 mg/kg/day intraperitoneal dose expressed as T/C1981Journal of medicinal chemistry, Aug, Volume: 24, Issue:8
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
AID110257Antileukemic activity of compound against the P-388 lymphocytic leukemic BDF1 male mice at 0.6(mg/kg)/day, administered intraperitoneally; 11.6/9.66 (Treated/control)1981Journal of medicinal chemistry, Aug, Volume: 24, Issue:8
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (28.57)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's10 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.56 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index61.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]